{"entity":{"type":"insider","cik":"0001305117","url":"/insider/0001305117","json_url":"/insider/0001305117.json","name":"TAUB MALCOLM S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":14,"first":"2010-04-30","last":"2015-12-16","span_basis":"filed_date"},"name_variants":[{"name":"TAUB MALCOLM S","source":"filing","n_filings":14,"first_seen":"2010-04-30","last_seen":"2015-12-16"}],"transactions":[{"id":8327666,"accession":"0001144204-15-071310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-071310","line_url":"/filing/0001144204-15-071310#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11263.0,"shares_display":"11,263","price_per_share":2.59,"price_display":"2.59","price_state":"stated","total_value":29171.17,"total_display":"29,171.17","total_whole":"29,171","shares_owned_after":8666.0,"shares_owned_after_display":"8,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-16","scope":"insider"},{"id":8327662,"accession":"0001144204-15-071310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-071310","line_url":"/filing/0001144204-15-071310#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30479.0,"shares_display":"30,479","price_per_share":2.61,"price_display":"2.61","price_state":"stated","total_value":79550.19,"total_display":"79,550.19","total_whole":"79,550","shares_owned_after":19929.0,"shares_owned_after_display":"19,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-16","scope":"insider"},{"id":8772214,"accession":"0001144204-15-070766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-15-070766","line_url":"/filing/0001144204-15-070766#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":2606.8,"total_display":"2,606.80","total_whole":"2,607","shares_owned_after":50408.0,"shares_owned_after_display":"50,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-14","scope":"insider"},{"id":8772213,"accession":"0001144204-15-070766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-15-070766","line_url":"/filing/0001144204-15-070766#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":2.74,"price_display":"2.74","price_state":"stated","total_value":34250.0,"total_display":"34,250.00","total_whole":"34,250","shares_owned_after":51388.0,"shares_owned_after_display":"51,388","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider"},{"id":9033514,"accession":"0001144204-11-041904","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-11-041904","line_url":"/filing/0001144204-11-041904#line-4","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.4554,"price_display":"0.46","price_state":"stated","total_value":45540.0,"total_display":"45,540.00","total_whole":"45,540","shares_owned_after":238333.0,"shares_owned_after_display":"238,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-08","filed_date":"2011-07-25","scope":"insider"},{"id":9120575,"accession":"0001144204-11-034760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-034760","line_url":"/filing/0001144204-11-034760#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33023.0,"shares_display":"33,023","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":9246.44,"total_display":"9,246.44","total_whole":"9,246","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-06","filed_date":"2011-06-08","scope":"insider"},{"id":8875720,"accession":"0001144204-11-031193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-11-031193","line_url":"/filing/0001144204-11-031193#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10250.0,"shares_display":"10,250","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":3075.0,"total_display":"3,075.00","total_whole":"3,075","shares_owned_after":33032.0,"shares_owned_after_display":"33,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-18","filed_date":"2011-05-19","scope":"insider"},{"id":8875718,"accession":"0001144204-11-031193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-031193","line_url":"/filing/0001144204-11-031193#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61400.0,"shares_display":"61,400","price_per_share":0.3002,"price_display":"0.30","price_state":"stated","total_value":18432.28,"total_display":"18,432.28","total_whole":"18,432","shares_owned_after":43282.0,"shares_owned_after_display":"43,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-17","filed_date":"2011-05-19","scope":"insider"},{"id":9130334,"accession":"0001144204-11-022009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-11-022009","line_url":"/filing/0001144204-11-022009#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165000.0,"shares_display":"165,000","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":49500.0,"total_display":"49,500.00","total_whole":"49,500","shares_owned_after":104682.0,"shares_owned_after_display":"104,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-13","filed_date":"2011-04-14","scope":"insider"},{"id":9130333,"accession":"0001144204-11-022009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-022009","line_url":"/filing/0001144204-11-022009#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":900.0,"total_display":"900.00","total_whole":"900","shares_owned_after":269682.0,"shares_owned_after_display":"269,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-12","filed_date":"2011-04-14","scope":"insider"},{"id":8984403,"accession":"0001144204-11-021369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-021369","line_url":"/filing/0001144204-11-021369#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":272682.0,"shares_owned_after_display":"272,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-07","filed_date":"2011-04-11","scope":"insider"},{"id":9140034,"accession":"0001144204-11-020502","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-11-020502","line_url":"/filing/0001144204-11-020502#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97966.0,"shares_display":"97,966","price_per_share":0.3011,"price_display":"0.30","price_state":"stated","total_value":29497.5626,"total_display":"29,497.56","total_whole":"29,498","shares_owned_after":277682.0,"shares_owned_after_display":"277,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-05","filed_date":"2011-04-06","scope":"insider"},{"id":9140033,"accession":"0001144204-11-020502","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-020502","line_url":"/filing/0001144204-11-020502#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":1950.0,"total_display":"1,950.00","total_whole":"1,950","shares_owned_after":375648.0,"shares_owned_after_display":"375,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-04","filed_date":"2011-04-06","scope":"insider"},{"id":9120514,"accession":"0001144204-11-020050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-11-020050","line_url":"/filing/0001144204-11-020050#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7354.0,"shares_display":"7,354","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":2206.2,"total_display":"2,206.20","total_whole":"2,206","shares_owned_after":382148.0,"shares_owned_after_display":"382,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-01","filed_date":"2011-04-04","scope":"insider"},{"id":9120513,"accession":"0001144204-11-020050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-020050","line_url":"/filing/0001144204-11-020050#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":389502.0,"shares_owned_after_display":"389,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-31","filed_date":"2011-04-04","scope":"insider"},{"id":9059174,"accession":"0001144204-11-016851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-016851","line_url":"/filing/0001144204-11-016851#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43630.0,"shares_display":"43,630","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":13089.0,"total_display":"13,089.00","total_whole":"13,089","shares_owned_after":409502.0,"shares_owned_after_display":"409,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-22","filed_date":"2011-03-24","scope":"insider"},{"id":9157435,"accession":"0001144204-11-015222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-015222","line_url":"/filing/0001144204-11-015222#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40400.0,"shares_display":"40,400","price_per_share":0.305,"price_display":"0.30","price_state":"stated","total_value":12322.0,"total_display":"12,322.00","total_whole":"12,322","shares_owned_after":453132.0,"shares_owned_after_display":"453,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-14","filed_date":"2011-03-16","scope":"insider"},{"id":8922217,"accession":"0001144204-11-014581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-014581","line_url":"/filing/0001144204-11-014581#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":15500.0,"total_display":"15,500.00","total_whole":"15,500","shares_owned_after":493532.0,"shares_owned_after_display":"493,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-10","filed_date":"2011-03-14","scope":"insider"},{"id":8946777,"accession":"0001144204-11-014103","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-11-014103","line_url":"/filing/0001144204-11-014103#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":15500.0,"total_display":"15,500.00","total_whole":"15,500","shares_owned_after":543532.0,"shares_owned_after_display":"543,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-09","filed_date":"2011-03-10","scope":"insider"},{"id":8946775,"accession":"0001144204-11-014103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-11-014103","line_url":"/filing/0001144204-11-014103#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81468.0,"shares_display":"81,468","price_per_share":0.3232,"price_display":"0.32","price_state":"stated","total_value":26330.4576,"total_display":"26,330.46","total_whole":"26,330","shares_owned_after":593532.0,"shares_owned_after_display":"593,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-08","filed_date":"2011-03-10","scope":"insider"},{"id":7133918,"accession":"0001144204-10-023644","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-10-023644","line_url":"/filing/0001144204-10-023644#line-2","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":225000.0,"shares_display":"225,000","price_per_share":0.2627,"price_display":"0.26","price_state":"stated","total_value":59107.5,"total_display":"59,107.50","total_whole":"59,108","shares_owned_after":675000.0,"shares_owned_after_display":"675,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2010-04-30","scope":"insider"},{"id":7133916,"accession":"0001144204-10-023644","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-10-023644","line_url":"/filing/0001144204-10-023644#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001305117","owner_name":"TAUB MALCOLM S","owner_display_name":"TAUB MALCOLM S","owner_url":"/insider/0001305117","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":0.2514,"price_display":"0.25","price_state":"stated","total_value":87990.0,"total_display":"87,990.00","total_whole":"87,990","shares_owned_after":900000.0,"shares_owned_after_display":"900,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-14","filed_date":"2010-04-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001137883","name":"BRAINSTORM CELL THERAPEUTICS INC.","url":"/issuer/0001137883","role":"Director","n_filings":14,"first_seen":"2010-04-30","last_seen":"2015-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001305117","retrieved_at":"2026-08-22T13:26:18+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}